相关产品推荐更多 >

iFluor™ 633 Anti-human CD45 Antibody *HI73*/iFluor™ 633 Anti-human CD45 Antibody *HI73*/iFluor™ 633 Anti-human CD45 Antibody *HI73*
询价
Scnn1b 多克隆抗体 (ATTO 655) | Scnn1b polyclonal antibody (ATTO 655)
询价
PE/iFluor™ 750 Anti-human CD11c Antibody *3.9*/PE/iFluor™ 750 Anti-human CD11c Antibody *3.9*/PE/iFluor™ 750 Anti-human CD11c Antibody *3.9*
询价
Nuclear Receptor Subfamily 1 Group D Member 1 (NR1D1) Antibody/Nuclear Receptor Subfamily 1 Group D Member 1 (NR1D1) Antibody/Nuclear Receptor Subfamily 1 Group D Member 1 (NR1D1) Antibody
询价
Anti-Human TNFSF13B|Anti-Human TNFSF13B
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
The immunogen for this antibody is: C-SIIYRMTNQKIRMD
- 保存条件:
Aliquot and store at -20℃
- 保质期:
1年
- 级别:
科研级别
- 库存:
100
- 供应商:
艾美捷科技
- 宿主:
山羊
- 应用范围:
E, WB, IHC, Flow
- 抗体英文名:
Renin Receptor Antibody
- 抗体名:
Renin Receptor Antibody
- 规格:
0.1mg
Renin Receptor 抗体,Renin Receptor Antibody,Renin Receptor 抗体,Renin Receptor Antibody
产品名称:Renin Receptor 抗体-Renin Receptor Antibody
产品货号:PSI-46-280-0.1mg
产品规格:0.1mg
背景资料:
保存建议:Renin Receptor 抗体-Renin Receptor AntibodyAliquot and store at -20℃
应用类型:E, WB, IHC, Flow
点击:Renin Receptor 抗体-Renin Receptor Antibody查看更详细产品说明,更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多ProSci公司特色试剂盒、特色抗体以及特色试剂等产品评论,请点击查看艾美捷特色产品中心。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Measuring Renin Secretion from Juxtaglomerular Cells
The development of specific receptor inhibitors of angiotensin II and the generation of genetic knockout models of the different components of the renin-angiotensin-aldosterone (RAAS) cascade has confirmed previous and has created new
Measurement of Plasma Renin Activity
Measurement of angiotensin 1, released in plasma by the action of endogenous enzyme renin on endogenous substrate, angiotensinogen is described. Details are given for the generation of angiotensin 1 from plasma using controlled conditions
Renin angiotensin aldosterone system (RAAS) activation plays an essential role in the development of cardiovascular disease (CVD). Multiple pathophysiologic processes are able to activate RAAS, among which hypertension, obesity, diabetes
技术资料暂无技术资料 索取技术资料







